about
Prodrugs of phosphonates and phosphates: crossing the membrane barrier(99m)Tc-labeled porphyrin-lipid nanovesicles.Ribonucleoside 3'-phosphates as pro-moieties for an orally administered drug.Visible Light Controlled Release of Anticancer Drug through Double Activation of Prodrug.Identification of an RNase that preferentially cleaves A/G nucleotides.
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Ribonuclease-Activated Cancer Prodrug.
@ast
Ribonuclease-Activated Cancer Prodrug.
@en
type
label
Ribonuclease-Activated Cancer Prodrug.
@ast
Ribonuclease-Activated Cancer Prodrug.
@en
prefLabel
Ribonuclease-Activated Cancer Prodrug.
@ast
Ribonuclease-Activated Cancer Prodrug.
@en
P2093
P2860
P356
P1476
Ribonuclease-Activated Cancer Prodrug.
@en
P2093
Gregory A Ellis
Michael J Palte
Nicholas A McGrath
P2860
P304
P356
10.1021/ML2002554
P577
2012-02-01T00:00:00Z